Meta-analysis of blood pressure levels and outcomes in type 2 diabetes participants
This meta-analysis examined the relationship between blood pressure levels and clinical outcomes in a large population of participants with type 2 diabetes. The investigation focused on systolic and diastolic blood pressure in relation to all-cause mortality, cardiovascular events, and renal outcomes. The analysis included secondary outcomes such as estimated glomerular filtration rate decline and albuminuria progression. The authors observed a J-shaped association for systolic blood pressure regarding mortality and cardiovascular events, with risks appearing flattened at lower levels after adjusting for baseline conditions.
The study found positive linear or monotonic trends for renal events and kidney function decline. These findings indicate that lower blood pressure levels were associated with better renal outcomes in this specific context. The authors noted that these patterns held true even when looking at the development or progression of albuminuria. The data suggests that previously reported risks associated with lower blood pressure might be misleading.
The authors highlight that dose-response relationships between blood pressure levels and risks remain poorly characterized, particularly at lower levels. They caution that previously reported associations are likely due to reverse causation and unmeasured confounding rather than direct harm. Consequently, low systolic blood pressure does not appear to be associated with an elevated risk of all-cause mortality compared with higher targets. Clinicians should interpret these findings with caution regarding blood pressure management goals.